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A Langendorf preparation with a left ventricular balloon 
was used to evaluate the isovolumetric function of six dog 
hearts before and after twenty-four hour preservation in a 
four-degree Celsius bath of intracellular-type fluid(ICF). 
Each heart served as its own control and cross-perfusion from 
a support dog was used during hemodynamic assessment of the 
isolated hearts. Mean left ventricular pressure development 
(LVPD), left ventricular positive dp/dt (LV dp/dt) and 
diastolic compliance were measured at baseline (pre-storage) 
and again 0.5, 1.0, 2.0, and 3.0 hours following twenty-four 
hour preservation and blood reperfusion. At each time point 
oxygen and lactate content were measured in samples of 
arterial and coronary sinus blood. Gravimetric water content 
was determined prior to storage and following three hours of 
reperfusion. 
All six hearts beat upon blood reperfusion and showed 
preserved contractile and metabolic function. The average 
LVPD and LV dp/dt reached baseline after two hours of 
reperfusion. The diastolic compliance after preservation 
(0.50 ± 0.26 mmHg), was significantly decreased from baseline 
(1.90 - 0.26 mmHg), but did not change during the three-hour 

V 
period of blood reperfusion. The water content of the left 
ventricular tissue increased from 78.7 ± 0.3 ml/lOOgm for 
freshly excised hearts to 82.1 + 0.4 ml/lOOgm after twenty- 
four hour storage and 3 hours of blood reperfusion (P<0.05). 
Oxygen consumption and lactate extraction after preservation 
were not significantly different from baseline values. 
We conclude that: 1) Twenty-four hour preservation by 
the simple technique of immersion in cold, intracellular-type 
fluid effectively preserves hemodynamic function as 
manifested in both pressure development (LVPD) and 
"contractility" (LV dp/dt); 2) Hemodynamic function is 
depressed initially after twenty-four hour preservation and 
subsequently improves progressively with blood reperfusion, 
reaching pre-preservation levels after three hours; 3) The 
recovery of hemodynamic function occurs despite decreased 
diastolic compliance and the presence of myocardial edema; 
and 4) Recovery of hemodynamic function corresponds with the 







A. The Shortage of Donor Hearts 
This past December 2nd marked the twentieth anniversary 
of the first human heart transplant by Dr. Christiaan Bernard 
in South Africa. Today heart transplantation is a real 
therapeutic technique for patients with end-stage heart 
disease partly due to the introduction of cyclosporine in 
1980 to combat rejection; In 1986 more than 2000 heart 
transplants were performed worldwide and it is predicted that 
about 4000 will have been performed in 1987(64). The most 
experienced centers report actuarial survival rates between 
80% and 100% at one year and 50% at five years. These rates 
compare favorably to 42% one-year survival for patients in 
need of organs but denied eligibility. Furthermore, 5% of 
Stanford's heart transplant recipients who have lived one 
year have been able to return to normal occupation and 
activity (67). 
Despite such clinical success and the improvements in 
treating rejection, cardiac transplantation is still faced by 
a major barrier—the ever present lack of donor organs! An 
estimated 14,000 people could benefit from a heart transplant 
every year in the United States (20) and at least 1000 of 
them (approximately one of four patients actually on a 
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waiting list) may die before a donor heart becomes available 
(13,83). Thanks in part to media coverage, the public 
awareness of the need for donor organs has increased. 
Nonetheless, the supply of donor hearts is likely to be even 
further reduced by the introduction of seatbelt laws, laws 
requiring the use of child-restraint seats, handgun laws, and 
motorcycle helmet laws (21). The fear of transplanting 
organs infected by Human Immunodeficiency Virus (HIV) is also 
likely to eliminate more potential donor organs from 
consideration in the coming years. 
Several years ago the use of cardiac xenografts (hearts 
taken from another animal species) promised to provide easy 
availability of donors. However, graft survival in animal 
testing has been poor and xenografting cannot be considered a 
viable alternative until the major problem of histoincompat- 
ibility is overcome (52,84). The questions of public 
acceptability and the possibility that animal organs may 
harbor infectious agents that may be transmitted to the human 
recipient must also be considered. 
The advent of the Jarvik artificial heart in 1982 also 
failed to eliminate the shortage of donor hearts and 
introduced other ethical and technical problems. Cardiac 
support by a mechanical device is currently a viable option 
for individuals whose clinical condition deteriorates while 
awaiting a human heart. However, as long as the shortage of 
transplantable human hearts exists, the use of temporary 
artificial hearts as "bridges" to a human heart cannot 
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increase the total number of human lives saved by heart 
transplants (1). Patients with artifical devices are given 
higher priority than patients being medically managed while 
awaiting a donor heart, thereby only changing the identity of 
the people who obtain the available human hearts. 
Since cardiac transplantation is not likely to be 
superseded soon by xenografting or artificial devices, the 
donor-shortage problem will need to be resolved if it is to 
develop fully as a therapeutic clinical procedure. Extending 
the effective period of storage of hearts will be one way to 
increase the donor pool; Long-term (twenty-four hour) storage 
will allow truely remote harvesting—essentially from all 
regions of the world— enabling the use of organs that would 
otherwise be "wasted". 
A recent retrospective review of 233 potential cardiac 
donors referred over six years to the University of Arizona 
Health Sciences Center showed that the largest category (31%) 
of all donor refusals consisted of 50 patients, otherwise 
acceptable, who were refused as cardiac donors because an 
ABO-compatible recipient was not readily available (18). 
This suggests that long-term storage will not only allow time 
for more in-depth histocompatability matching, but would also 
effectively expand the donor pool by providing time to 
distribute organs to ABO-compatible recipients. 
The current method of heart procurement in most active 
transplant centers utilizes storage of the donor hearts in a 
bucket filled with sterile saline at four degrees Celsius. 
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Experimental and clinical studies have shown that good 
protection achieved in this manner is limited to four to six 
hours (4,8,14,57). The present study evaluates the use of an 
intracellular-type fluid that mimicks the normal ion 
composition of fluid in cells for long-term myocardial 
preservation. Its design was based on established principles 
of myocardial protection and the experiences of other 
investigators in the field of organ preservation. 
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B. Principles of Myocardial Protection 
A heart may suffer ischemic damage during harvesting 
from the donor or during the operation to transplant it into 
the recipient. However, Burt and Copeland recently 
quantified the decrement in function of rabbit hearts at each 
step in the transplantation process and found that the 
greatest damage occurs during the period of cold storage(11). 
The challenge to protect the heart during this time of cold 
ischemia is similar to the problem encountered during cardiac 
surgical procedures such as coronary artery bypass grafting 
and valvular replacement. Ideally the solutions used for 
cardioplegic protection during clinical open-heart surgery or 
for organ storage should: 1) provide immediate pharmacologic 
arrest to lower energy demands and avoid energy depletion by 
ischemic electromechanical work; 2) use hypothermia to reduce 
energy demands further and prevent recurrence of 
electromechanical activity; 3) provide substrates for 
continued aerobic or anaerobic activity; and 4) prevent or 
reduce unfavorable interstitial and cellular changes such as 
edema(9). 
Potassium has been the mainstay of almost all 
cardioplegic and organ-preservation solutions since solutions 
containing high potassium concentrations were first used in 
1955 to facilitate cardiac surgery(45,55). Extracellular 

7 
hyperkalemia provides immediate cardiac arrest by 
depolarizing cell membranes and produces a state of sustained 
diastole. The blockade of contractile activity minimizes 
oxygen demand and eliminates ATP-expending actin-myosin 
interaction. The safe upper limit of potassium concentration 
remains unclear. However, Tyers et al. found that functional 
deterioration equivalent to that seen with sixty minutes of 
normothermic ischemic arrest resulted only when hyperkalemia 
twenty-five times in excess of that required to arrest the 
heart (about 10 mEq/L) was used(76). 
Hypothermia is also used in organ protection to reduce 
energy requirements and oxygen demand. The question of the 
optimal temperature to achieve maximal protection cannot be 
unequivocally answered from the available data. Angell and 
Griepp and their colleagues demonstrated in two separate 
studies with canine hearts that the duration of allowable 
ischemia is a linear function of the logarithm of 
temperature(2,31). These studies and another by Tyers et al. 
using isolated rat hearts (75) found that saline or Krebs- 
Henseleit (extracellular-ion composition) buffers at ten to 
fifteen degrees Celsius gave better functional and metabolic 
preservation for relatively short-term(one to four hour) 
cardiac ischemia than four degree or twenty degree Celsius 
solutions. In contrast, Swanson et al. observed that canine 
hearts preserved at four degrees Celsius for five hours 
functioned at levels equal to or greater than hearts stored 
at fifteen degrees Celsium and they found no evidence of 
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myocardial damage attributable to the cooler temperature 
alone(71). 
The studies mentioned above were in agreement that 
temperatures approaching zero degrees, even for short 
periods, had a deleterious effect. Although red blood cells 
and bone marrow are successfully preserved by freezing, only 
limited success has been achieved using cryopreservation of 
hearts. Offerijns and Krijnen found that good preservation 
of rat hearts in a supercooled state (-18 degrees Celsius) 
for longer periods than one or two hours was impossible even 
though dimethyl sulfoxide (DMSO) was employed as a 
cryoprotectant(60). Likewise, Bausamian et al. found that 
freezing of puppy hearts at -2 degrees Celsius produced 
irreversible injury precluding resuscitation(3). However, 
using a combination of mechanical dehydration and glycerol 
saturation, the same group successfully transplanted several 
puppy hearts that had been cooled to -8 degrees Celsius for 
several hours without freezing. Therefore, these 
investigators concluded that it is the insult of freezing 
and thawing, not cooling per se, that irreversibly damages 
hearts. 
The relative importance of hypothermia and potassium- 
based chemical cardioplegia in myocardial protection has also 
been studied. It appears clear that they have separate and 
additive properties(34,72). 
Details of the molecular mechanisms involved in tissue 
injury are presently unknown. Purported mechanisms include 
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depletion of the cellular high-energy phosphate supply, 
accumulation of toxic waste products, and alteration of 
transmembrane ionic gradients with resultant cellular 
swelling (37) . Effective hypothermia and cardioplegic arrest 
appear to preserve cytosolic adenosine triphosphate (ATP) 
levels well (25,42). It has also been well established that 
the cellular swelling that characterizes both ischemia and 
hypothermia can be greatly reduced by making preservative 
solutions hyperosmolar by the addition of solutes such as 
glucose or mannitol (27,28,49). Other compounds, including 
steroids and phenothiazines as "membrane-stabilizers", have 
been used in attempts to aid myocardial protection. In fact, 
so many agents were being tested that Katz was prompted to 
calculate that about a million experiments could be done to 
characterize the interactions and effects of just thirty 
cardioplegic solutions(39)! In the discussion that follows, 
some of the most promising and more recent approaches to the 
problem of long-term cardiac preservation will be reviewed. 
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C. Techniques of Long-Term Preservation 
The first successful attempt to maintain hearts outside 
of the body for more than a few hours is attributed to 
Lindbergh, who in 1935 used a self-contained, pulsatile 
perfusion apparatus(51). In vitro perfusion has remained a 
popular technique for long-term preservation of the heart. 
In 1969 Feemster et al. used hyperbaric, pulsatile 
perfusion at twenty-four degrees Celsius (with a continuously 
fibrillating heart) to attempt long-term cardiac preservation 
(24). Many other workers have used continuous, low-pressure, 
hypothermic (four to ten degrees Celsius) perfusion with more 
success. This technique is thought to provide a continual 
supply of oxygen and substrates as well as removal of waste 
products. Proctor and Parker introduced low-pressure 
perfusion in 1968 and preserved dog hearts for 72 hours with 
return of "strong contractions", as judged by gross 
observation, upon blood reperfusion(63). In the early 1970s, 
several groups of investigators demonstrated survival of 
animals following orthotopic transplantation with grafts 
preserved for 24 to 28 hours using this technique(17,62,74). 
Trunkey et al.(1970) used oxygenated, filtered canine plasma 
and mimicked contractions with external compression by a 
silastic balloon to perfuse hearts without edema. Eight 
hearts preserved in this manner for twenty-four hours 
initially functioned well after orthotopic transplantation, 

11 
but began to fail after four hours(74). Proctor et al.(1971) 
transplanted sixteen hearts following 72 hours of perfusion 
with Krebs crystalloid with survival in ten animals up to a 
maximum of fourteen hours(62). Copeland et al.(1973) also 
used hypothermic perfusion with a modified Krebs solution, 
along with pretreatment of the donor animal with 
phenoxybenzamine and glyceryl trinitrate. An overall surival 
rate of 30% was achieved at twenty-four hours following 
orthotopic transplantation of the preserved hearts (17). 
Encouraged by these earlier reports, Guerraty et 
al.(1981) performed a similar study using canine hearts 
preserved twenty-four hours with continuous hypothermic 
perfusion with modified Krebs solution. However, the 
addition of post-operative immunosuppression to their 
protocol improved survival to 73% at one day following 
orthotopic transplantation and a 20% survival rate was 
achieved at thirty days post-op(32). In addition, Miller et 
al.(1984) stored hearts for twenty-four hours with continuous 
perfusion with oxygenated Krebs at five degrees Celsius and 
compared this method of preservation to simple-storage (non- 
perfused) in a five-degree bath of Ringer's lactate. 
Ventricular pressure development and positive dp/dt were 
measured following orthotopic transplantation. The 
ventricular function of the hearts preserved by perfusion was 
virtually identical to control, untransplanted hearts in 
open-chest dogs. The hearts stored in the cold bath of 




Wicomb and his colleagues in South Africa used this 
technique to perfuse baboon hearts for twenty-four hours and 
after orthotopic transplantation achieved consistent survival 
until rejection(16,81). Following this success in the 
experimental laboratory, Wicomb et al.(1984) reported the 
only clinical use to-date of hearts following long-term 
preservation. Four patients underwent heterotopic 
transplantation with donor hearts preserved from seven to 
seventeen hours by continuous perfusion with oxygenated, 
hyperosmolar, standard cardioplegia. Three of the four donor 
hearts required considerable support by the recipient 
circulation and inotropes for up to twenty-four hours post-op 
and in two cases the donor hearts would not have supported 
the circulation initially if orthotopic transplantation had 
been performed. All four hearts subsequently recovered 
normal function, although one failed shortly secondary to 
acute rejection(80). 
Despite the attention that perfusion techniques have 
received, it is apparent that perfusion per se is not 
absolutely essential for successful preservation. The choice 
of storage solution also seems to play a significant role in 
determining the outcome of organ storage. As will be 
described shortly, intracellular-type fluids have been used 
very successfully both to perfuse isolated hearts 
continuously for twenty-four hours and for simple, non- 
perfused storage. Furthermore, orthotopic transplantation is 
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not the only way in which cardiac function has been assessed 
following preservation. Like the present study, 
Bethencourt(7) and Levitsky(50) used intraventricular 
balloons to study the function of isolated canine hearts 
perfused with cold, modified Krebs solution and canine plasma 
respectively. A comparison of ventricular function curves 
for the preserved hearts versus a group of control hearts 
demonstrated that good preservation was achieved. 
In the future, several relatively new approaches may 
prove beneficial in prolonging the viable hypothermic 
ischemia time. Fluosol DA, a perfluorochemical with a very 
high oxygen-carrying capacity is being used experimentally as 
a myocardial protectant (19,35,38,43). Free radical 
scavengers, such as superoxide dismutase, seem to prevent 
the injury caused by oxygen free radical generation during 
blood reperfusion of stored organs(69). Constant-strength, 
high intensity magnetic fields have also been found to reduce 
mitochondrial injury in preserved hearts(29). 

14 
C. The Use of Intracellular-Type Fluid (ICF) for Organ 
Preservation 
Theoretical value of ICF. Biopsies of ischemic 
myocardium show that hypothermia and standard cardioplegia 
are able to maintain high levels of cytosolic ATP. However, 
immediately upon reperfusion with warm blood and the onset of 
contractions, there is a rapid fall in ATP. ATP levels may 
reach or fall below the association constant of critical 
enzymes such as the sodium-potassium ATPase and the sodium- 
calcium ATPase (25). This loss of ATP is most likely 
associated with its utilization to restore transmembrane 
ionic gradients that were disrupted by ischemia and 
hypothermia. Although hypothermia reduces energy 
requirements and ATP expenditure by slowing metabolic 
processes, it directly suppresses the ATPase sytem that 
normally regulates ion distribution across cellular 
membranes—i.e. ATPase suppression results in potassium and 
magnesium loss, and sodium and chloride gain by the cell(54). 
The increase in intracellular osmotic force passively 
draws water into the cells. The resultant cellular swelling 
may obstruct small vessels and worsen the actual ischemic 
tissue damage(48). In addition, as intracellular potassium 
levels fall, extracellular calcium enters the cell more 
readily. Suppression of the normal ATP-dependent sodium- 
calcium exchange mechanism by cold and/or ischemia or due to 
a relative deficiency of ATP following reperfusion allows 
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intracellular calcium to rise to high levels. Eventually 
myocardial contracture such as is seen with "stone hearts" or 
"reperfusion injury" may result(9,26). 
Unlike standard, extracellular-type media such as 
saline, Krebs' solution, or Ringers lactate, intracellular- 
type fluid(IGF) is thought to prevent or reduce such 
detrimental changes in ATP levels and ion distribution in 
stored organs. ICF mimicks the normal composition of fluid 
within cells, especially the high potassium and low sodium 
concentrations, causing ions to equilibrate across cellular 
membranes at intracellular concentrations. Therefore, during 
cold storage in ICF, intracellular potassium and sodium 
levels will in theory remain unchanged. Normal transmembrane 
gradients and effective electromechanical function will be 
readily reestablished upon blood reperfusion. In this way, 
the use of ICF eliminates the considerable ATP expenditure 
which would be needed to regenerate transmembrane ionic 
gradients and diminishes cellular swelling and calcium uptake 
and the resultant sequelae (9,30). 
The Use of ICF for Kidney and Lung Preservation. The 
use of ICF for enhancement of hypothermic organ preservation 
was first described by Keeler et al. over twenty years ago 
(40). Subsequent studies by Collins(1969) and Sacks(1973) 
convincingly demonstrated the effectiveness of simple bathing 
in cold ICF to preserve canine kidneys for 30 to 72 hours 
(15,66). These studies again demonstrated the clear benefit 
of pharmacologic preservation in addition to the protection 

16 
afforded by hypothermia alone. Collins' and Sacks' solutions 
are still used clinically and make international exchange of 
renal allografts possible. These solutions are also 
currently used in clinical lung transplantation, since the 
only satisfactory results in lung preservation have been 
obtained with intracellular-type solutions (33,59,73). 
ICF and Cardiac Preservation. Clinical use of ICF for 
human heart transplantation has not yet been attempted. 
However, a number of investigators have studied 
intracellular-type fluids for preservation of animal hearts. 
Kohno et al.(1987) preserved isolated rat hearts for four 
hours at zero degrees Celsius in a bath of Collins' solution 
and compared the myocardial cation contents during storage 
and reperfusion to those in hearts stored in a standard, low 
potassium-high sodium, cardioplegia. ICF indeed prevented 
myocardial sodium accumulation and potassium depletion during 
storage and myocardial sodium and calcium overload after 
reperfusion compared with the standard cardioplegia (41). 
This study supports the theory that the benefits of ICF are 
not solely due to potassium-induced diastolic arrest of the 
heart. 
Feeley et al.(1986) also used Collins' solution for 
short-term canine heart preservation. This group attempted 
en bloc heart-lung storage for five hours in a four-degree 
Celsius bath of Collins' solution. After combined heart-lung 
transplantation recipient dogs succumbed secondary to 
pulmonary edema, but cardiac function was adequately 
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preserved. The cardiac output was also better in 
transplanted animals following Collins'-storage than after 
storage with standard cardioplegia (23). 
Other investigators have used ICF for intermediate- 
length (eight to fourteen hours) cardiac preservation with 
variable success. In 1972, Caiman and Bell perfused isolated 
rat hearts with Collins' solution at five-degrees Celsius for 
fourteen hours. The hearts were evaluated after 
reestablishing circulation by connecting them to the aorta 
and vena cava of an intact "recipient" rat. To be scored as 
"viable", electrocardiographic evidence of electrical 
activity was necessary and the heart had to beat continuously 
for at least ten minutes following reperfusion. Hearts 
perfused with Collins' solution had very poor viability 
(<10%) in comparison to hearts perfused with standard 
cardioplegic solutions containing insulin, 15% dextran-40 and 
phenoxybenzamine (12). 
As part of their study to define the limits of 
hypothermic preservation, Griepp et al.(1974) stored five 
canine hearts in a bath of four-degree Celsius Collins's 
solution for twelve hours. Post-storage function was 
assessed by orthotopic transplantation with an average 
survival of 21 hours, reflecting "borderline organ viability" 
(31). Sewell et al.(1978) achieved much better results by 
using immunosuppression to evaluate chronic animal survival 
following orthotopic transplantation. Six canine hearts were 
transplanted after eight hours of simple refrigeration at 
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eight-degrees Celsius in Collins' solution. All six 
recipient dogs survived the perioperative period although 
atrial pacing and dilute norepinephrine and dopamine drips 
were required for the initial six to twelve hours. Two dogs 
died secondary to non-cardiac causes within the first month. 
The other four dogs survived and underwent cardiac 
catheterization at one month post-op which demonstrated 
normal filling pressures, ejection fraction, and cardiac 
output (68). 
Twenty-Four Hour Cardiac Preservation with ICF. Tables 
1 and 2 present the composition and experimental design of 
the previous studies which have used intracellular-type 
fluids for long-term (24 hour) preservation of canine hearts. 
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Studv Bayliss Reitz* Thomas* Watson* Suzuki Present 











Sodium 30 10 14 14 16 16 16 10 15 
Potassium 130 115 126 126 130 117 117 115 130 
Calcium 0.1 1.0 -- 
Magnesium 2 30 16 16 16 60 60 6 3 
Chloride 30.1 15 16 16 16 15 15 15 15 
Phosphate 100 100 120 120 100 100 100 95 160 
Sulfate 2 30 60 60 6 3 
Bicarbonate 130 10 20 20 20 20 20 10 20 
Glucose(g/L) — 25 — — 20 20 20 14 20 
Dextrose(g/L) 10 — 










5% Lidocaine — 
— 







4 4 4 4 3 3 4 4 
Oxvoenation No No No No No Yes Yes No No 
Osmolaritv 354 
(mOsm/L) 
330 430 430 460- 
480 
460 460 410 480 
Table 1. Composition of Intracellular-type Solutions used for 
24-Hour Cardiac Preservation. 
*Investigators using two intracellular-type solutions 
**mEq/L except where otherwise specified 
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Studv: Bayliss Reitz Thomas Watson Suzuki Present 
(1970) (1974) (1975) (1977) (1984) (1988) 
N= 10 11/7 12/15 6/6 5 6 
Storage simple simple simple a)perfused perfused simpl 





24 hrs. 18-26 
hrs. 
24 hrs. 24 hrs. 24 hrs. 24 hrs 
Assess- gross, ortho. hetero. ortho. LV balloon LV 







4 4 3 4 4 
Table 2: Design of 24-Hour Preservation Studies Using ICF 
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Bayliss and Maloney(1970) were the first investigators 
to use ICF for cardiac storage. They placed ten canine 
hearts in a bath of ICF and a second group of control hearts 
was stored in Normosol (extracellullar-type solution) for 
twenty-four hours at zero degrees Celsius. The hearts stored 
in Normosol did not regain an effective beat upon blood 
reperfusion from a support dog. In contrast, all ten of the 
hearts stored in ICF "beat vigorously" and regained 
electrical activity for the full three-hour evaluation period 
following reperfusion(6). 
Reitz et al.(1974) also reported effective twenty-four 
hour preservation of canine hearts using a simple hypothermic 
bath of ICF. Reitz evaluated eleven hearts stored in 
Collins' solution and seven more stored in Sacks' solution by 
orthotopic transplantation. As evident in table 1, Sacks' 
solution has approximately the same intracellular ion 
composition as Collins' solution, but is made hyperosomolar 
with mannitol. All eighteen hearts were easily defibrillated 
upon reperfusion with warm blood and supported the 
circulation once weaned off of cardiopulmonary bypass 
although eleven required a continuous isoproterenol infusion. 
Fourteen out of the eighteen recipient animals were weaned 
from the ventilator and lived eight hours to five and one- 
half days with four surviving until rejection. Only one of 
three hearts stored similarly in Krebs' solution could be 
defibrillated and it did not support the circulation (65). 
Thomas et al.(1975) confirmed Reitz's findings with 
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Sacks ' solution (about 25% survival to rejection) and also 
described a new solution with even higher osmolarity that 
yielded a 93% survival rate. The viability of preserved 
hearts was assessed by gross observation, ventricular 
pressure measurements, and electrocardiographic tracings 
following heterotopic transplantation into the neck of 
recipient dogs. Twelve hearts were stored in a simple bath 
of Sacks' solution at four-degrees Celsius for twenty-four 
hours. All were resuscitated but only three (25%) survived 
until rejection at five to twenty-six days. Fourteeen of the 
fifteen hearts (93%) stored in Thomas' new, hyperosmolar 
solution survived beyond six days to rejection (range six to 
fifty-seven days) (72). 
Watson(1977) performed the next studies of cardiac 
preservation with ICF. He compared simple refrigeration to 
continuous perfusion using foxhound hearts and orthotopic 
transplantation. Six donor hearts were perfused 
continuously at three-degrees Celsius for twenty-four hours 
with oxygenated ICF. Six other hearts were suspended in a 
bath of cold, oxygenated ICF. Of the twelve donors, six 
perfused and four nonperfused grafts survived the twenty-four 
hour post-transplant period. Two nonperfused grafts died 
within two hours after weaning from bypass secondary to 
intractable tachyarrythmias. More severe damage was also 
noted on gross examination of the nonperfused hearts although 
they had an average weight loss of 5% in contrast to the 34% 
average weight gain of the perfused hearts (78). 
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In a separate study using the same intracellular-type 
solution, Watson and his colleagues compared continuous to 
intermittent perfusion for 48-hour preservation. Seventeen 
foxhound hearts were perfused continuously with oxygenated 
ICF for 48 hours at three-degrees Celsius. Six others were 
stored for 48 hours using 15 minute cycles of oxygenated 
perfusion and non-perfusion. Following orthotopic 
transplantation, all six(100%) of the intermittently perfused 
and four(24%) of the continuously perfused hearts survived 
the 24-hour postoperative period. Several of the recipient 
animals required ventricular pacing and all of them were 
continuously supported by dopamine infusions and ventilated 
postoperatively. The dogs were sacrificed 24 hours after 
transplantation and there was a significant weight gain for 
both sets of hearts; 58% for intermittently-perfused and 86% 
for the continuously-perfused hearts (79). 
The only other, and most recent, evaluation of ICF for 
24-hour preservation was performed in Japan by Suzuki et 
al.(1984). Five isolated canine hearts were refrigerated at 
four-degrees Celsius while a modified Collins' solution was 
perfused retrogradely into the the coronary sinus. A left 
ventricular balloon was used to study the hearts following 
storage and three of them were also assessed by orthotopic 
transplantation. There was no weight change in the hearts, 
all five had normal end-systolic pressure-volume ratios, and 
the three transplanted hearts supported the circulation for a 





E. Experimental Design 
The present study was undertaken to reevaluate simple, 
hypothermic, twenty-four hour storage with a fundamental 
intracellular-type solution. Previous investigators have 
judged the success of ICF-preservation by subjective, gross 
observation or by orthotopic transplantation. Although 
survival of the animal with the orthotopically transplanted 
heart is a practical endpoint, survival as an "all-or-none" 
phenomenon does not adequately quantitate graft function. 
Therefore, a particular objective of this study was to 
perform precise assessment of hemodynamic and metabolic 
parameters of ventricular function. 
To accomplish this we chose the technique developed by 
Opie and Gorlin for isolated rat hearts (22,61) and 
subsequently modified by Holdefer and Edwards(36) for canine 
hearts. An intraventricular balloon was placed into a basic 
Langendorf preparation(46) which uses a non-working, isolated 
heart supported by retrograde coronary perfusion from a 
support animal. This model allows heart rate and preload to 
be controlled while another determinant of mechanical 
performance, the inotropic state is evaluated. It also has 
the advantage of perfusing the isolated hearts with a 
biologic medium at the appropriate temperature and level of 
oxygenation. 
Reitz and Thomas achieved successful myocardial 
preservation using simple immersion of hearts in cold ICF. 
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For the present study, the convenience of simple storage in 
ICF was also felt to outweigh the unproven benefits of 
continuous perfusion,. Our storage solution was designed to 
be cheap and easy to prepare and store. Therefore, unlike 
some of the previous ICF studies (Table 7) the solution was 
kept very fundamental; It was not oxygenated and did not 
contain other agents such as steroids, fluorocarbons or 
phenoxybenzamine. The ICF was made hyperosmolar with 
mannitol and glucose and cooled to four degrees Celsius 
since, as discussed above, there is a theoretical basis and 
experimental evidence to support the use of both 
hyperosmolality and hypothermia in organ preservation. 
No attempt was made to compare the efficacy of our ICF 
with that of any other solution or to compare simple storage 
to a more complex perfusion system. This study also used 
each heart as its own control with pre- and post-preservation 
assessment as has been recommended(50) but only rarely 
attempted previously(71,74) with isolated hearts. 
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III. MATERIALS AND METHODS 
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III. MATERIALS AND METHODS 
A. Preparation of the Langendorf Heart: 
As discussed above, the well-known Langendorf 
preparation (46) was used to achieve coronary perfusion of 
the isolated heart from the arterial circuit of a support 
dog. All experimentation was approved by and conducted under 
the supervision of the Animal Care Division. 
Six mixed-breed dogs weighing 20kg to 25kg were obtained 
from Paradis Animal Farm (Brookshire, VT). The animals were 
anesthetized with sodium pentobarbitol (Abbot Laboratories, 
North Chicago, IL) and maintained on a respirator (Harvard 
#607, Harvard Apparatus Co., Millis, MA). Anticoagulation 
was provided with heparin (Elkins-Sinn, Cherry Hill, NJ). 
The heart was exposed through a median sternotomy and the 
azygous vein was ligated. The venae cavae, brachiocephalic 
artery, and the transverse aortic arch were sequentially 
ligated as 500 milliliters of four-degree Celsius standard 
operating room cardioplegia (K+ 25 mEq/L) was infused into 
the coronary arteries through a cannula in the subclavian 
artery. The inferior vena cava was incised to decompress the 
right ventricle and iced saline was used for topical 
hypothermia. The cardioplegia administration brought about 
rapid hypothermic and metabolic arrest and the heart was then 
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rapidly excised and placed in an iced cardioplegia bath. A 
soft latex balloon was connected to a central high pressure 
tube and was placed in the left ventricular cavity following 
excision of the mitral valve chordae tendinae. The balloon 
was mounted on a rubber plug which was held securely in place 
by a purse-string suture through the mitral valve annulus. 
The balloons were pre-stretched and their intrinsic 
distensibility checked to ensure that the material itself 
made a negligible contribution to the end-diastolic pressure. 
The stiff rubber plug needed to be positioned carefully so 
that it would not interfere with the competence of the aortic 
valve. Retrograde aortic flow from the support dog, if 
allowed direct access to the left ventricle via a leaky 
aortic valve, would have invalidated both the balloon and 
metabolic measurements. In addition, the left atrial 
remnants were sewn tightly over the rubber plug to ensure 
that the left ventricle would contract isovolumetrically as 
the balloon was inflated. 
The cannula coming from the balloon emerged from the 
rubber plug and was connected to a pressure transducer 
(Gould-Statham, Oxnard, CA) for measurement of left 
ventricular pressure (LVP). Positive left ventricular dp/dt 
(LV dp/dt) was obtained by differentiating the LVP signal. 
Vents made of 3/16th inch Silastic tubing (Dow Corning Corp., 
Midland, MI) were placed in both ventricles to collect the 
Thebesian and coronary sinus flow. Epicardial pacing wires 
were placed on the surface of the heart and connected to a 
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demand pacemaker (Medtronics, Minneapolis, MN) set to 
maintain a minimum heart rate of 100 beats per minute. A 
cannula was placed in the aorta and then attached to a 
circuit for cross-perfusion from the femoral artery of a 
support dog (Figure 1). Care was taken to empty all air from 
the aorta before beginning perfusion. The circuit was primed 
with 300 milliliters of heparinized blood taken from the 
donor dog before excision of the heart. The average time to 
excise the heart, prepare it with the balloon and vents, and 
to then connect it to the perfusion circuit was 40 minutes. 
The heart was kept bathed in iced saline as much as 
technically possible during this preparation. 
Following preparation, the isolated heart was cross- 
perfused retrogradely through the aorta with warm, oxygenated 
blood from the femoral artery of a heparinized, anesthetized 
support dog. The coronary artery perfusion pressure was 
monitored at the aortic root and maintained at 80 to 100 mmHg 
by controlling the flow from the support dog with a large C- 
clamp. The drainage from the two vents was collected in a 
one-liter, water-jacketed chamber (Yale Glassworks Lab, New 
Haven, CT), maintained at thrity-seven degrees Celsius by a 
heat exchanger (Travenol Labs, Deerfield Ill.), and returned 


























































B. Functional Evaluation 
Electrical defibrillation was used if defibrillation did 
not occur spontaneously upon perfusion of the heart in the 
support circuit. A thirty minute period of stabilization was 
allowed before baseline (pre- twenty-four hour preservation) 
data was recorded. 
Hemodynamic assessment The isovolumetric left 
ventricular function was then evaluated by infusion of saline 
into the left ventricular balloon in five milliliter 
increments up to twenty milliliters while measuring LVPD and 
LV dp/dt. Care was taken to prevent air bubbles from 
entering the intraventricular balloon. During this period of 
assessment, the heart was kept suspended well above the fluid 
in the collection chamber, since submersion changed the 
transmural pressure and influenced the left ventricular 
pressure tracings. The optimal balloon volumes were 
determined during the initial preservation experiment. 
Figure 2 illustrates that volumes of five to twenty 
milliliters clearly place this heart on the ascending portion 
of the "Starling Curve" of ventricular function. These 
balloon volumes are in accordance with those used in other 
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Balloon Volume (milliliters) 
Figure 2: Pressure Development Versus Balloon Volume (Expt. #1) 
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Metabolic assessment and determination of water content 
Myocardial water content was determined by weight difference 
before and after drying biopsies of left ventricular muscle 
to constant weight. Control water content was determined 
similarly from samples from freshly excised hearts. Arterial 
and coronary sinus lactate levels were determined to allow 
calculation of lactate extraction: [(arterial lactate - 
coronary sinus lactate)/(arterial lactate)]. Oxygen content 
(volume %) was also measured in arterial and coronary sinus 
blood to allow calculation of oxygen extraction: [(arterial 
oxygen content - coronary sinus oxygen content)/ (arterial 
oxygen content)]. Coronary sinus drainage from the right 
ventricular vent (ml/min) was multiplied by the arterial- 
coronary sinus oxygen difference to yield values for 
myocardial oxygen consumption. 
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C. Preparation of Intracellular Fluid and Twenty-Four Hour 
Storage 
After obtaining the baseline data, the intraventricular 
balloon was emptied and the isolated heart was again rapidly 
arrested, this time by flushing approximately lOOcc of four- 
degree Celsius intracellular-type fluid (ICF) into the 
coronary arteries as the blood flow from the support dog was 
interrupted. When the coronary sinus flow became clear, the 
heart was completely submerged in a one-liter bath of cold, 
unoxygenated ICF and placed into a refrigerator. A 
thermistor was placed into the left ventricular chamber via 
the LV vent and the temperature was maintained at four- 
degrees Celcius throughout the twenty-four hour storage 
period. 
The ICF was modelled after other intracellular-like 
fluids with high osmolarity which have been studied 
previously (see Table 1 above). The recipe (Table 3), 
yielded the ionic concentrations noted in Table 4 as 
determined by the clinical chemistry laboratory. 
A relatively low concentration of magnesium was used 
since, as noted in previous studies also (5,65), magnesium 
phosphate crystals tended to form spontaneously when more 
magnesium sulfate was added. Such a precipitate could be 
detrimental if it were to occur in the coronary vasculature 
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Potassium phosphate monobasic 2.05 
Potassium phosphate dibasic 9.70 
Potassium chloride 1.12 
Potassium bicarbonate 2.30 
Sodium bicarbonate 1.25 
Magnesium sulfate hydrate 7.40 
Glucose 20.0 
Mannitol 25.0 
Table 3. Recipe for Intracellular Fluid (qm/L) 
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during storage of the hearts. 
The ICF was prepared separately for each experiment. 
Although the compounds used are all quite water soluble (82) , 
each was brought into solution completely using double- 
distilled water before the next compound was added. The 
compounds were added in the order listed in Table 3. Careful 
preparation of the ICF in this manner was necessary to 
prevent insoluble complex ions, such as magnesium phosphate 
tribasic, from forming secondary to locally high ion 
concentrations. The ICF was refrigerated at four-degrees 
Celsius overnight and was then filtered through a 22 micron 
Whatman filter prior to use. The ICF in the storage bath was 
replaced with fresh solution after eight and again after 
sixteen hours of storage. 
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D. Blood Reperfusion 
After twenty-four hours of hypothermic storage in the 
ICF bath, the heart was rewarmed by cross-perfusion from a 
support dog and again electrically defibrillated when the 
myocardial temperature reached thirty degrees Celsius. 
During the initial period of reperfusion, all coronary venous 
effluent was discarded. The function tests performed during 
the baseline evaluation were repeated 0.5, 1.0, 2.0, and 3.0 
hours following restoration of supraventricular rhythm. 
During both pre- and post-storage functional evaluations, the 
arterial blood gases, pH, hematocrit, and arterial blood 
pressure of the support dog were monitored and maintained 
within normal physiologic range. No inotropic agents were 





















7.2 at 4 C 
Table 4. Composition of Intracellular Fluid 
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E. Handling of Hemodynamic Data 
All values of left ventricular pressure development 
(LVPD) and left ventricular positive dp/dt (LV dp/dt) were 
extracted from the chart recorder tracings as averages for 
ten consecutive heartbeats. The LVPD for a single cardiac 
cycle was calculated as the end-systolic left ventricular 
pressure minus the end-diastolic left ventricular pressure. 
For each heart, post-preservation values of LVPD and LV dp/dt 
at each time point were expressed as a percentage of baseline 
values for that heart at all four balloon volumes. These 
normalized values were then averaged to determine the 
percent-baseline function for that heart at each time point. 
The overall adequacy of twenty-four hour preservation was 
judged by compiling the percent-baseline data for all six 
hearts for these hemodynamic parameters. 
Diastolic compliance was measured at baseline and at 
each reperfusion time point. Compliance was calculated as 
deltaV/deltaP for the end-diastolic pressures as the balloon 
was inflated from five to twenty milliliters. 
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F. Statistical Analysis 
All results are presented as means plus/minus the 
standard error of the mean. The mean values obtained 
following preservation were compared with the baseline data 
using the paired Student's T-test with differences considered 
significant for values of p< 0.05. 
The diastolic compliance curves were fitted to a 
straight line by linear regression using the least-squares 
method, with a coefficient of determination (r-squared) 







A. Pressure Development and Contractility 
Upon blood reperfusion all six hearts stored for twenty- 
four hours were easily electrically defibrillated at a 
temperature of thirty degrees Celsius and maintained a 
supraventricular rhythm at a rate of 100 to 140 beats per 
minute throughout the three-hour period of evaluation. Five 
out of six hearts beat regularly without significant 
arrythmias. The sixth heart had a persistent irregularly 
irregular rhythm which interferred with the functional 
assessment using the intraventricular balloon. However, when 
a bolus of lidocaine was given to the support dog, periods of 
regular rhythm resulted which facilitated the data 
collection. At the end of all six experiments, the latex 
balloon was found to conform uniformly to the walls of the 
left ventricular chamber. 
As noted above, balloon volumes of five to twenty 
mililiters represented a "preload" that placed the hearts on 
the ascending portion of the ventricular function curve. As 
shown for the first experiment, Figure 2, at balloon volumes 
greater than thirty mililiters ventricular function was 
depressed. At much higher volumes the left ventricle was 
visibly distended and beating weakly and the perfusion 
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pressure at the aortic root was greatly increased. The LV 
dp/dt for this heart showed similar response to changes in 
balloon volume (Figure 3). Furthermore, overdistension of 
the left ventricle following two hours of blood reperfusion, 
resulted in significantly poorer subsequent function. 
Table 5 contains the average values of LVPD and LV dp/dt 
for the six hearts at a balloon volume of twenty milli¬ 
liters. These values put the levels of percent-baseline 
function determined for all four balloon volumes (Table 6, 























Balloon Volume (milliliters) 
















30 Minutes Reperfusion 39 ± 5 1788 ± 377 
60 Minutes Reperfusion 54 ± 10 2300 ± 551 
2 Hours Reperfusion 72 ± 10 4021 ± 1060 
3 Hours Reperfusion 69 ± 12 4000 ± 1318 




Figure 4 illustrates the chart recorder data obtained 
for a representative, twenty-four hour preserved heart after 
three hours of blood reperfusion (~ 28 hours post excision) 
at a balloon volume of twenty mililiters. Figure 5 contains 
the ventricular function curves, LVPD versus balloon volume, 
for the same representive heart. Left ventricular function 
was significantly depressed after thirty minutes of 
reperfusion and improved progressively with LVPD approaching 












(Measured @ Aortic Root) 

VOLUME OF INTRAVENTRICULAR BALLOON 
Figure 5: Ventricular function curves for ..a. representative 
isolated heart at baseline and after twenty-four 
hours of preservation and blood reperfusion 
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The general trend of hemodynamic recovery during 
reperfusion, demonstrated by the single heart above, was 
observed for all six hearts. The composite hemodynamic data 
for the six hearts is presented in Table 6 and graphically in 
figures 6 and 7. Ventricular pressure development and 
positive dp/dt were both significantly depressed thirty 
minutes after the start of reperfusion. Both LVPD and LV 
dp/dt increased during the next several hous and were not 
statistically different from baseline after two hours of 
reperfusion. 
Heart no. 1, see Figures 2 and 3, apparently sustained 
an air embolus during the start of perfusion for its baseline 
evaluation. This probably accounts for the smaller absolute 
values of pressure development and LV dp/dt seen for this 
heart. Nonetheless, this heart also demonstrates the general 
trend of hemodynamic recovery upon reperfusion until it was 




%Baseline LVPD_%Baseline LV dp/dt 
Baseline 100 100 
30 Minutes Reperfusion 48 ± 6 45 ± 10 
60 Minutes Reperfusion 64 ± 8 66 ± 12 
2 Hours Reperfusion 90 ± 8 122 ± 25 
3 Hours Reperfusion 78 ± 6 116 ± 25 
Table 6. Percent-Baseline LVPD and LV dp/dt Averaged for all 
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Figure 7: Recovery of Left Ventricular Pressure Development (N=6) 
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B. Myocardial Compliance and Water Content (Table 7) 
The average diastolic compliance after storage and 
thirty minutes of reperfusion decreased considerably to 0.50 
ml/mmHg ± 0.04 from a baseline of 1.9 ml/mmHg ± 0.26 
(p<0.05). There was no further change at the subsequent 
reperfusion time points with a compliance of 0.52 ml/mmHg ± 
0.03 after three hours of reperfusion. There was a 
concomitant increase in gravimetric heart water from a 
control value of 78.7 + 0.03 ml/100 grams for freshly excised 
hearts to 82.1 ± 0.4 ml/100 grams for hearts after storage 




30 Minutes Reperfusion 
60 Minutes Reperfusion 
2 Hours Reperfusion 
3 Hours Reperfusion 
Compliance 
(ml/minHg) 
1.90 ± 0.26 
0.50 ± 0.04 
0.55 ± 0.04 
0.52 ± 0.03 
0.52 ± 0.03 
Water Content 
(ml/lOOgm) 
78.7 ± 0.3 
82.1 ± 0.4 
Table 7. Diastolic Complicance and Water Content 
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C. Metabolic Function(Tables 8 and 9) 
Lactate extraction was seen in all six hearts during the 
baseline evaluation. In contrast, all six hearts were 
producing lactate after storage and thirty minutes of 
reperfusion. During the next two hours the six hearts tended 
to increase their lactate extraction and three of them gave 
evidence of aerobic metabolism by consuming lactate from the 
arterial blood (positive lactate extraction ratios) after 
three hours of reperfusion. The average lactate extraction 
ratio at three hours of reperfusion was not statistically 
different from baseline. Likewise, the myocardial oxygen 
consumption and oxygen extraction ratios during the 
reperfusion period did not differ significantly from the 
baseline ratios. In addition, the support dogs' femoral 
artery lactate concentration at baseline (1.3 mmol/L 1 0.3) 
was not significantly different from the average value during 
the reperfusion studies (1.5 mmol/L + 0.5 at 30 minutes 
reperfusion, 1.2 mmol/L + 0.3 at three hours reperfusion). 

Baseline 0.18 + 0.01 
30 Minutes Reperfusion -0.60 + 0.37 
60 Minutes Reperfusion -0.32 + 0.09 
2 Hours Reperfusion -0.16 + 0.05 
3 Hours Reperfusion -0.06 + 0.06 
Table 8. Lactate Extraction Ratios fN=6) 
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Oxygen Extraction Ratio 
Baseline 0.28 ± 
30 Minutes Re. 0.44 ± 
60 Minutes Re. 0.34 ± 
2 Hours Re. 0.47 ± 
3 Hours Re. 0.42 ± 
Oxygen Consumption 
0.06 2.8 + 0.6 
0.06 2.7 + 0.5 
0.03 2.5 + 0.6 
0.09 3.5 + 0.7 
0.07 2.8 + 0.7 








Cardiac transplantation for patients with end-stage 
cardiac disease is currently limited by a natural constraint- 
—the availability of donor organs. Long-term mechanical 
circulatory support and successful, socially-acceptable 
xenografting are unlikely to supercede the use of human heart 
transplantation in the reasonably near future. Therefore, 
the development of a clinically effective method of long-term 
cardiac preservation is needed if the shortage of donor 
hearts is going to be alleviated. 
This study was designed to reevaluate the use of simple 
bathing in cold intracellular fluid (ICF) for twenty-four 
hour cardiac preservation. Previous studies with simple ICF 
storage evaluated cardiac function subjectively or by 
transplantation. We used an isolated, "non-working" heart 
with isovolumetric contraction on an intraventricular 
balloon. Each heart's own post-preservation function was 
compared to its own baseline (pre-storage) function. The 
intraventricular balloon allowed precise measurement of the 
first derivative of the ventricular pressure curve (LV dp/dt) 
which has been shown to be a good measure of inotropic state 
in experimental animals(77). Left ventricular pressure 
development (LVPD) was also readily determined with the 
intraventricular balloon and demonstrated the important 
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ability of the heart to generate pressure independently above 
the diastolic "filling pressure" presented by the inflated 
balloon. 
The comparison to baseline LV dp/dt and LVPD (Table 6, 
Figures 6 and 7) demonstrates that hyperosmolar ICF afforded 
excellent twenty-four hour preservation. Function was 
clearly transiently depressed after storage, but adequate 
function was regained following two hours of blood 
reperfusion. Not surprisingly, improvement in contractile 
performance corresponded with a return of metabolic function 
towards baseline aerobic metabolism as evidenced by positive 
lactate extraction. The oxygen consumption after storage 
also compares well with Levitsky's reported values following 
twenty-four hour preservation with canine plasma(50). The 
steady femoral artery lactate concentrations at baseline and 
during reperfusion suggest that the support dogs' metabolic 
state did not influence the performance of isolated hearts. 
The mean LV dp/dt of 2750 + 537 at baseline compares 
favorably with previously reported control values of 2960± 
180(47) and 1310+ 109(50) which were also obtained with the 
intraventricular balloon technique. In a non-ejecting, 
isolated heart the clinical significance of these values is 
difficult to interpret. However, they are also similar to 
previous in vivo control values of 1550 ±220, 2000± 590 
mmHg/sec(44) and 1275 mmHg/sec(57). This suggests that the 
six preserved hearts in this study recovered to a contractile 
state that would meet physiologic demands. The average LVPD 
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of 69 itunHg following twenty-four hour storage and three hours 
of blood reperfusion also reflects the integrity of 
contractile function to within a normal physiologic range. 
Following clinical transplantation, positive inotropic agents 
would be available to further enhance cardiac performance. 
The baseline values of myocardial water content agree 
very well with previously reported control values(47,42). 
The baseline value for diastolic compliance, 1.90 ±0.26 
ml/mmHg, is virtually identical to a previous in vivo control 
value of 1.95±0.30 ml/mmHg(44). The post-preservation weight 
gain and decreased compliance (82.1 ±0.4 ml/lOOgm and 0.52± 
0.03 ml/mmHg respectively) are also in agreement with prior 
studies. Laks and Bethencourt reported values of 82.8 ±0.32 
ml/lOOgm and 0.65± 0.14 ml/mmHg after twenty-four hour 
storage in modified Krebs solution and three hours of 
reperfusion(7). Kolata et al. reported a water content of 
82.3 ± 0.8 ml/lOOgm after twenty-four hour storage in a 
standard extracellular-type solution(42). 
Without further measurements at intermittent time points 
it is impossible to correlate the compliance changes with 
changes in water content. Since compliance remains unchanged 
throughout the reperfusion period as ventricular 
contractility improves markedly, decreased compliance does 
not appear to prevent good hemodynamic function. This 
confirms the poor relationship between compliance and 
hemodynamic function noted by previous investigators (7,80). 
Furthermore, survival following transplantation is not 
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predicted well by the weight gain during preservation (17). 
In light of the encouraging results achieved in this 
study further laboratory investigation of ICF seems 
warranted. While the isolated-heart model provides precise 
hemodynamic evaluation, and has been used extensively in the 
literature, it has several inherent shortcomings. It 
provides no certainty that function of the preserved heart 
would be as good in the "working" state and in vivo 
evaluation with precise hemodynamic measurements would be the 
ultimate test of ICF's clinical utility. In addition, the 
function of the preserved heart was studied only for the 
brief three-hour period. It would be important to confirm 
that good hemodynamic function continues. 
A short-term orthotopic transplantation study with full 
hemodynamic assessment would confirm function of the 
"working" heart and would allow clinically meaningful 
parameters such as cardiac output and ejection fraction to be 
measured. Subsequently, a long-term survival study with 
precise hemodynamic assessment initially and at intervals 
would confirm hemodynamic function is sustained. It would 
also provide the opportunity to see if edema resolves and 
diastolic compliance increases. Previous studies have 
indicated that myocardial ultrastructure may be damaged 
before functional deterioration is evident by routine 
measurements of contractility (10,53). Therefore, histolog¬ 
ical studies during ICF preservation would be informative. 
In addition, since high concentrations of potassium are 
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extremely irritating to peripheral veins, further studies of 
its effect on the coronary vasculature are needed. The 
effect of ICF on cardiac antigenicity also needs to be 
evaluated. 
It is unclear why earlier studies with ICF yielded 
inconsistent results. The present study was carefully 
designed to take full advantage of the theoretical benefits 
of ICF in an attempt to optimize preservation. ICF is felt 
to prevent myocardial damage during hypothermic storage and 
electromechanical arrest with high extracellular potassium by 
maintaining the integrity of transmembrane ionic gradients. 
Therefore, during rewarming and reperfusion the cells do not 
need to expend ATP to reestablish the normal ionic gradients 
and transmembrane voltage potential. The ATP which is saved 
might then be available to meet other needs of the cell 
including actin-myosin interaction. 
Measurement of ions, including calcium, and ATP levels 
during the various stages of preservation and reperfusion 
might demonstrate whether or not ICF works in this manner. 
Increasing the magnesium concentration to a true intracellular 
level of about fifteen mEq/L might also improve preservation. 
Magnesium occurs in the myocardium chelated to ATP and it is 
also lost from the cell during ischemia or reperfusion. Since 
magnesium functions, in part, to inhibit mitochondrial uptake 
of calcium, its loss is felt to be associated with irreversible 
damage in post-ischemic myocardium (26,58). The speed of 
rewarming following cold storage might also be important, but 
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was not investigated in this study. 
Lastly, the technique of cardiac preservation 
investigated—simple immersion in cold ICF— is so simple that 
transition to clinical practice would be straightforward. Cold 
ICF may also prove to be advantageous for short-term (four to 







This study confirms the favorable results that have been 
achieved using simple storage of hearts in hypothermic, hyper¬ 
osmolar intracellular-type fluid (ICF). It also demonstrates 
that it is possible to use each heart as its own control in an 
isolated, "non-working" model. We conclude that: 
1. Twenty-four hour preservation by the simple technique 
of immersion in cold ICF effectively preserves hemodynamic 
function as manifested in both pressure development (LVPD) 
and "contractility" (LV dp/dt). This was accomplished 
without the use of inotropic support; 
2. Hemodynamic function is depressed initially after 
twenty-four hour preservation and subsequently improves 
progressively with blood reperfusion, reaching pre¬ 
preservation levels after three hours; 
3. Recovery of hemodynamic function occurs despite 
decreased diastolic compliance and the presence of 
myocardial edema; and 
4. Recovery of hemodynamic function corresponds with the 
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